Skip to main content

Table 2 Significant differentially expressed miRNA profile in UA patients treated with or without statin

From: Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina

Whole blood

Score(d)

Fold change

q-value(%)

Plasma

Score(d)

Fold change

q-value(%)

hsa-miR-191

3.9826

2.0182

<0.0001%

hsa-miR-21

4.0676

9.6700

<0.0001%

hsa-miR-92a

3.8634

2.6235

<0.0001%

hsa-miR-223

3.4159

8.6072

<0.0001%

hsa-miR-532-3p

3.3904

2.4110

<0.0001%

hsa-miR-106a

3.1782

5.9014

<0.0001%

hsa-miR-574-3p

3.1517

2.7277

<0.0001%

hsa-miR-17

3.0701

5.7191

<0.0001%

hsa-miR-30b

3.0671

2.2520

<0.0001%

hsa-miR-320

2.7697

7.9742

<0.0001%

hsa-miR-486-5p

3.0474

2.2180

<0.0001%

hsa-miR-24

2.5543

5.1630

<0.0001%

hsa-miR-223

3.0328

2.3800

<0.0001%

hsa-miR-146b-5p

2.4747

16.9902

<0.0001%

hsa-miR-30c

2.9640

2.1134

<0.0001%

hsa-miR-142-3p

2.4040

16.8645

<0.0001%

hsa-miR-484

2.9314

2.4529

<0.0001%

hsa-miR-19b

2.3810

7.1494

<0.0001%

hsa-miR-451

2.8041

3.1920

<0.0001%

hsa-miR-19a

2.2580

9.1338

<0.0001%

hsa-miR-331-3p

2.6506

1.8440

<0.0001%

hsa-miR-30a-5

2.1183

9.2122

<0.0001%

hsa-miR-25

2.6181

2.3039

<0.0001%

hsa-miR-222

2.0399

8.4189

<0.0001%

hsa-miR-222

2.5022

2.0910

<0.0001%

hsa-miR-126

2.0359

7.1429

<0.0001%

hsa-miR-652

2.4739

2.4337

<0.0001%

hsa-miR-451

1.9745

9.8249

<0.0001%

hsa-miR-19b

2.4250

2.0244

<0.0001%

hsa-miR-197

1.9738

2.7519

<0.0001%

hsa-miR-15b

2.2769

2.2809

<0.0001%

hsa-miR-92a

1.9470

6.4763

<0.0001%

hsa-miR-140-3p

2.2018

1.9416

<0.0001%

hsa-miR-20a

1.9312

6.8796

<0.0001%

hsa-miR-26a

2.1192

2.3774

<0.0001%

hsa-miR-29a

1.8389

4.4884

<0.0001%

hsa-miR-324-3p

2.1131

1.8923

<0.0001%

hsa-miR-146a

1.7932

7.7389

<0.0001%

hsa-miR-150

2.0946

1.7147

<0.0001%

    

hsa-miR-93

2.0697

2.4706

<0.0001%

    

hsa-miR-106a

2.0101

2.2727

<0.0001%

    
  1. 22 whole blood miRNAs and 19 plasma miRNAs were significantly different between the statin treatment group and the control group.